Trial Profile
A phase I/IIa trial of AU-105 in patients with glioblastoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Mar 2016
Price :
$35
*
At a glance
- Drugs AU 105 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 16 Mar 2016 New trial record